Sentences with phrase «issue of the journal cancers»

Writing in the current issue of the journal Cancer Research, the team notes, however, that a combination of therapies will most likely be required to obtain significant clinical results.

Adult drug resistant cancer cells may contribute to this problem, and the authors discuss these and other cancer drug resistance mechanisms in their recent publication in the September issue of the journal Cancers.

Their findings, to be published in the July issue of the journal Cancer Cell, could explain why some tumors don't respond to radiation or chemotherapy, and provide novel routes for the development of new anti-cancer therapies.

SPRINGFIELD, Mo., and NEW YORK, October 24, 2017 — Fight Colorectal Cancer (Fight CRC) and the Cancer Research Institute (CRI) are proud to announce «A Blueprint to Advance Colorectal Cancer Immunotherapies» will be published in the November 2017 issue of the journal Cancer Immunology Research (published online ahead of print on October 16, 2017).

The finding, detailed in the May issue of the journal Cancer Epidemiology, Biomarkers & Prevention, supports the idea that persistent exposure to secondhand tobacco smoke in childhood can contribute to the development of cancer later in life, said study team member Stephen Hecht of the Cancer Center at the University of Minnesota.

The study will be published in an upcoming issue of the journal Cancer.

Not exact matches

In response to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention, American Beverage Association consultant Dr. Richard Adamson, former director of the Division of Cancer Etiology, National Cancer Institute, issued the following statement:

She considers issues of justice and accessibility, because, as she wrote in the American Journal of Bioethics, while «cancer and infertility are conditions that afflict all women equally and traverse class, race and ethnic lines, social and economic distinctions generally determine health care access.»

In a study featured in the December issue of The Journal of Nuclear Medicine, Australian researchers demonstrate that PET scans can identify which of these prostate cancer patients would benefit from salvage radiation treatment (SRT).

Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, according to a research published in the July issue of the journal Nature.

By taking a high - cost drug with a low - fat meal — instead of on an empty stomach, as prescribed — prostate cancer patients could decrease their daily dose, prevent digestive issues and cut costs by 75 percent, according to a new study in the March 28, 2018, issue of the Journal of Clinical Oncology (JCO).

They announced their findings this week in the online issue of the Journal of the National Cancer Institute.

The findings, published in the Feb. 11 issue of the New England Journal of Medicine, could fundamentally change the way this cancer and others are treated.

Their clinical explanation for when to use and how to interpret thyroid cancer tests is published in the July issue of the scientific journal Thyroid.

The number of breast cancer patients undergoing immediate breast reconstruction operations after mastectomy has grown steadily over the past 15 years, most notably among women who were once considered too high - risk for reconstruction procedures according to new research findings published in the October 2014 issue of the Journal of the American College of Surgeons.

The study — the largest to date assessing the mental and emotional health of patients with cancer using a fully standardized, diagnostic face - to - face interview — is published in the October 6 issue of the Journal of Clinical Oncology.

An editorial in the same issue of the journal notes that drug - based treatments for liver cancer are limited and that the UT Southwestern study showed «truly remarkable results that should prompt further research under preclinical settings, given its potential to lead to a paradigm shift in treatment.»

These findings were published by researchers from Loyola University Health System in the latest issue of the International Journal of Gynecological Cancer.

In an article titled, «Allergen Induced Pulmonary Inflammation Enhances Mammary Tumor Growth and Metastasis: Role of CH13L1,» featured on the cover of the current issue of the Journal of Leukocyte Biology, this new research suggests inflammation raises the level of a known biomarker of cancer, called «chitinase -3-like-1» or «CHI3L1,» in the inflamed tissue, which leads to increased metastasis and faster cancer growth in that tissue.

In a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body).

«Emotional distress may motivate men with low - risk prostate cancer to choose more aggressive treatment, such as choosing surgery over active surveillance,» said UB's Heather Orom, the lead author on the study, published in the February issue of the Journal of Urology.

«After the cancer is controlled, the quality of life, which often includes the ability to have a normal child, becomes a major issue,» said Marvin Meistrich, a University of Texas oncologist, writing in the journal Pediatric Blood & Ccancer is controlled, the quality of life, which often includes the ability to have a normal child, becomes a major issue,» said Marvin Meistrich, a University of Texas oncologist, writing in the journal Pediatric Blood & CancerCancer.

The finding, published in the current issue of the journal Nature Communications, could lead to new therapies for treating a common sub-type of GBM and possibly other forms of cancer.

The test, described in tomorrow's issue of the journal Circulation, might be used to devise better antioxidant vitamin therapies against free radicals and to explore the mechanism of these compounds in cancer and other diseases.

A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, in research published in the August 2015 issue of The Journal of Nuclear Medicine.

The study was published in the December issue of Experimental Hematology, the official publication of the Society for Hematology and Stem Cells, and also highlighted in the journal's editorial due to its significance in the biology and treatment of blood cancer.

In this special theme issue of the Journal of the Academy of Nutrition and Dietetics, food and nutrition practitioners and other health professionals take an in - depth look at the relationship between nutrition, obesity, and cancer prevention, treatment, and survival and identify research gaps for future prevention research efforts.

In a study in the current issue of the American Journal of Preventive Medicine, researchers found that women working rotating night shifts for five or more years appeared to have a modest increase in all - cause and CVD mortality and those working 15 or more years of rotating night shift work appeared to have a modest increase in lung cancer mortality.

They report their work, which was funded by the Cancer Research Campaign, in this month's issue of the American journal Cancer Research.

The findings, published online in the July issue of the journal EBioMedicine, may have important implications for breast cancer screening and prevention.

The WHO study, one of a collection of articles in a special issue of the journal devoted to women's health beyond reproduction, found that the leading causes of death of women aged 50 years and older worldwide are cardiovascular disease (heart disease and stroke) and cancers, but that in developing countries these deaths occur at earlier ages than in the rich world.

The results published in the October issue of the Journal of Thoracic Oncology, the official journal for the International Association for the Study of Lung Cancer, show that TNI levels were undetectable in all patients before RT and increased slightly in 2 patients following RT but these returned to undetectable levels at the first folloJournal of Thoracic Oncology, the official journal for the International Association for the Study of Lung Cancer, show that TNI levels were undetectable in all patients before RT and increased slightly in 2 patients following RT but these returned to undetectable levels at the first follojournal for the International Association for the Study of Lung Cancer, show that TNI levels were undetectable in all patients before RT and increased slightly in 2 patients following RT but these returned to undetectable levels at the first follow - up.

Older people who are starting to have memory and thinking problems, but do not yet have dementia may have a lower risk of dying from cancer than people who have no memory and thinking problems, according to a study published in the April 9, 2014, online issue of Neurology ®, the medical journal of the American Academy of Neurology.

The growth rate of the cells exploded, and they quickly became disorganized masses characteristic of early stage, aggressive breast cancer, the team reports in the 7 February issue of the Journal of Experimental Medicine.

For women undergoing breast cancer surgery, a technique called lipofilling — using the patient's own fat cells to optimize the results of breast reconstruction — does not increase the risk of recurrent breast cancer, reports a study in the February issue of Plastic and Reconstructive Surgery ®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

A new study published in the Oct. 9 issue of the journal Nature Medicine demonstrates, for the first time, that glioblastoma (GBM), the most common and most lethal brain tumor, is driven by two distinct subsets of cancer stem cells.

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon - 11 labeled sarcosine (11C - sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Medcancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of MedCancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Medicine.

Writing in the January 6, 2015 issue of the journal Prostate Cancer and Prostatic Disease, a team of scientists and physicians from the University of California, San Diego School of Medicine, with counterparts at University of California, Los Angeles, describe a novel imaging technique that measurably improves upon current prostate imaging — and may have significant implications for how patients with prostate cancer are ultimately trCancer and Prostatic Disease, a team of scientists and physicians from the University of California, San Diego School of Medicine, with counterparts at University of California, Los Angeles, describe a novel imaging technique that measurably improves upon current prostate imaging — and may have significant implications for how patients with prostate cancer are ultimately trcancer are ultimately treated.

November 15, 2006 Risk after colon cancer higher for very fat and very thin Even after successful treatment for colon cancer, the very obese are about one - third more likely to have their cancer recur and to die prematurely from cancer than those of normal weight, researchers from the University of Chicago and the University of Pittsburgh report in the November 15, 2006, issue of the Journal of the National Cancer Instcancer higher for very fat and very thin Even after successful treatment for colon cancer, the very obese are about one - third more likely to have their cancer recur and to die prematurely from cancer than those of normal weight, researchers from the University of Chicago and the University of Pittsburgh report in the November 15, 2006, issue of the Journal of the National Cancer Instcancer, the very obese are about one - third more likely to have their cancer recur and to die prematurely from cancer than those of normal weight, researchers from the University of Chicago and the University of Pittsburgh report in the November 15, 2006, issue of the Journal of the National Cancer Instcancer recur and to die prematurely from cancer than those of normal weight, researchers from the University of Chicago and the University of Pittsburgh report in the November 15, 2006, issue of the Journal of the National Cancer Instcancer than those of normal weight, researchers from the University of Chicago and the University of Pittsburgh report in the November 15, 2006, issue of the Journal of the National Cancer InstCancer Institute.

One group of small, non-coding RNA molecules could serve as a marker to improve cancer staging and may also be able to convert some advanced tumors to more treatable stages, report a University of Chicago - based research team in the April 1, 2008, issue of the journal Genes & Development.

Researchers at The Institute of Cancer Research reported in the journal Nature Reviews Drug Discovery (January 2013 issue) that they have found a new way of rapidly prioritizing the best druggable targets online.

(HealthDay)-- Palbociclib can help slow the progression of advanced breast cancer, according to a study published in the Nov. 17 issue of the New England Journal of Medicine.

DENVER — Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging, and treatment in 2015, the International Association for the Study of Lung Cancer (IASLC) announces the inaugural publication of «Scientific Advances in Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology cancer prevention, diagnosis, staging, and treatment in 2015, the International Association for the Study of Lung Cancer (IASLC) announces the inaugural publication of «Scientific Advances in Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology Cancer (IASLC) announces the inaugural publication of «Scientific Advances in Lung Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology Cancer 2015» in the May 2016 issue of the IASLC's Journal of Thoracic Oncology (JTO).

Aug 8, 2008 Two New Predisposition Genes For Breast, Thyroid And Kidney Cancers Could Lead to More Accurate Diagnosis and Earlier Detection of These Cancers Charis Eng, MD, PhD, Sondra J and Stephen R Hardis Endowed Chair of Cancer Genomic Medicine and Chair, GMI, and her team published in the Aug 8, 2008 issue of the American Journal of Human Genetics that germline mutations in SDHB and SDHD, which play key roles in the mitochondria (the cell's power houses), predispose to Cowden and Cowden - like syndromes.

New findings published in the Journal of Clinical Oncology reveal that older patients who have undergone cancer surgery are at a higher risk of injuries or other health issues.

Recently, research led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute and published in the March 26 issue of the Journal of the American Medical Association (http://jama.ama-assn.org/cgi/content/abstract/299/12/1437), suggests genetic variety may be associated with decreased cancer risk.

Their strategy, described in the Jan. 4, 2009 issue of the journal Nature Medicine, could not only prove a very useful method to faithfully reproduce different types of tumors but also to elucidate the nature of elusive cancer stem cells.

DENVER — Three manuscripts published in the recent issue of the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC), explored the versatility of liquid biopsies by identifying EGFR mutations using circulating tumor DNA (ctDNA) in urine and plasma and examining circulating tumor cells (CTCs) in plasma to predict the risk of lung cancer recurrence after surgical resJournal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC), explored the versatility of liquid biopsies by identifying EGFR mutations using circulating tumor DNA (ctDNA) in urine and plasma and examining circulating tumor cells (CTCs) in plasma to predict the risk of lung cancer recurrence after surgical resjournal of the International Association for the Study of Lung Cancer (IASLC), explored the versatility of liquid biopsies by identifying EGFR mutations using circulating tumor DNA (ctDNA) in urine and plasma and examining circulating tumor cells (CTCs) in plasma to predict the risk of lung cancer recurrence after surgical reseCancer (IASLC), explored the versatility of liquid biopsies by identifying EGFR mutations using circulating tumor DNA (ctDNA) in urine and plasma and examining circulating tumor cells (CTCs) in plasma to predict the risk of lung cancer recurrence after surgical resecancer recurrence after surgical resection.

In experiments reported in the February 12, 2009, issue of the journal Nature, the scientists identified 10 metabolites that become more abundant in prostate cells as cancer progresses.